RSDGX | VMGIX | RSDGX / VMGIX | |
Total Expense Ratio | 1.40 | 0.19 | 737% |
Annual Report Gross Expense Ratio | 1.53 | 0.19 | 805% |
Fund Existence | 29 years | 19 years | - |
Gain YTD | 3.435 | 13.334 | 26% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 86.9M | 32.3B | 0% |
Annual Yield % from dividends | 0.00 | 0.51 | - |
Returns for 1 year | 18.16 | 25.14 | 72% |
Returns for 3 years | 5.72 | 55.52 | 10% |
Returns for 5 years | -36.41 | 62.58 | -58% |
Returns for 10 years | -52.13 | 184.28 | -28% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBB | 143.12 | 2.77 | +1.97% |
iShares Biotechnology ETF | |||
VGM | 9.71 | 0.16 | +1.68% |
Invesco Trust Investment Grade Municipals | |||
IPB | 25.72 | 0.02 | +0.06% |
Merrill Lynch Depositor | |||
UJUN | 36.36 | -0.03 | -0.08% |
Innovator U.S. Equity Ultra BffrETF™-Jun | |||
CANQ | 29.41 | -0.04 | -0.15% |
Calamos Nasdaq® Equity & Income ETF |